BeautiTone Serum

For skin conditions

• Uneven and/or dull skin tone
• Dehydrated and/or irritated skin
• Dry and flaky skin
• Signs of photoaging

What’s so special about BeautiTone Serum

• Powerful and Effective:
  BeautiTone Serum is formulated specifically for managing skin discoloration; brightening the skin tone and improving pore size and skin texture. It also helps to take care of sensitive skin and/or irritated skin conditions.
• Gentle and Safe:
  By using fewer ingredients, avoiding notorious skin irritating and sensitizing ingredients in this formula, eliminating fragrance, alcohol and colorant, this product is made to be gentle, safe and can easily be accepted by all skin types. Oil free also allows oily skin types to enjoy the benefits of this product without worrying about clogging the pores.

How to use

• Apply a few drops evenly to the face and neck 1-2 times daily avoiding the eye area.

How to maximize the benefits from BeautiTone Serum

• Use BeautiTone Serum before any product containing oil.
• Apply a generous amount of BeautiTone Serum evenly to the face and neck. twice daily. For skin discoloration areas use at least 2 to 3 times a day.
• Wear sun protection for outdoor activities for better results.
• Keep the cap tightly closed when not using.
• Re-order before running out for long term skin care.

Storage

• Place in a dry, cool place away from direct sunlight.

Ingredients

• Water, N-Acetylglucosamine, Niacinamide, Alpha-Arbutin, Glycerin, Sodium Citrate, Propanediol, Glycine Betaine (Beta Vulgaris) Sugar Extract, Sodium Hyaluronate (vLMW), Beta-Glucan, Dipotassium Glycyrrhizinate, Polyacrylate Crosspolymer-6, Allantoin, Sodium Gluconate, Phenoxyethanol, Xanthan Gum, Citric Acid, Ethylhexylglycerin.

Knowledge Base

• https://www.engineeringevil.com/2012/08/16/n-acetyl-glucosamine-and-niacinamide-significantly-reduced-the-amount-and-appearance-of-hyperpigmentation-age-spots-and-uneven-melanin-distribution/
• https://www.ncbi.nlm.nih.gov/pubmed/19691938
• https://www.ncbi.nlm.nih.gov/pubmed/17716251